CN108186937A - A kind of aloetic anti-acne drug and preparation method thereof - Google Patents
A kind of aloetic anti-acne drug and preparation method thereof Download PDFInfo
- Publication number
- CN108186937A CN108186937A CN201810193532.XA CN201810193532A CN108186937A CN 108186937 A CN108186937 A CN 108186937A CN 201810193532 A CN201810193532 A CN 201810193532A CN 108186937 A CN108186937 A CN 108186937A
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- full leaf
- aloetic
- aloe full
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 229940079593 drug Drugs 0.000 title claims abstract description 45
- 230000003255 anti-acne Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 67
- 241001116389 Aloe Species 0.000 claims abstract description 65
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 40
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 40
- 239000000843 powder Substances 0.000 claims abstract description 37
- 210000000582 semen Anatomy 0.000 claims abstract description 37
- 238000003825 pressing Methods 0.000 claims abstract description 18
- 238000013329 compounding Methods 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000011049 filling Methods 0.000 claims abstract description 3
- 238000004806 packaging method and process Methods 0.000 claims abstract 2
- 239000002775 capsule Substances 0.000 claims description 36
- 239000000463 material Substances 0.000 claims description 28
- 239000000945 filler Substances 0.000 claims description 9
- 238000000227 grinding Methods 0.000 claims description 9
- 238000007689 inspection Methods 0.000 claims description 9
- 238000012797 qualification Methods 0.000 claims description 9
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 21
- 206010000496 acne Diseases 0.000 abstract description 21
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 206010033733 Papule Diseases 0.000 abstract description 4
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract description 4
- 208000017701 Endocrine disease Diseases 0.000 abstract description 3
- 208000003351 Melanosis Diseases 0.000 abstract description 3
- 208000030172 endocrine system disease Diseases 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 3
- 231100000241 scar Toxicity 0.000 abstract description 3
- 206010000060 Abdominal distension Diseases 0.000 abstract description 2
- 206010014080 Ecchymosis Diseases 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 2
- 206010022437 insomnia Diseases 0.000 abstract description 2
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 abstract description 2
- 229920003266 Leaf® Polymers 0.000 description 56
- 230000000694 effects Effects 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 235000017443 Hedysarum boreale Nutrition 0.000 description 4
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 208000001749 optic atrophy Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 239000010282 Emodin Substances 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 201000005111 ocular hyperemia Diseases 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000883966 Astrophytum capricorne Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000062995 Cassia occidentalis Species 0.000 description 1
- 235000001948 Cassia occidentalis Nutrition 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000183712 Cerinthe major Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010064390 Tumour invasion Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- -1 anthraquinone compounds Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000009400 cancer invasion Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to medical anti-acne fields more particularly to a kind of aloetic anti-acne drug and preparation method thereof, which is grouped as by each group of following parts by weight:8 19 parts of aloe full leaf freeze-dried powder, 18 37 parts of aloe full leaf ovendry power, 28 parts of Radix Glycyrrhizae, 8 17 parts of cassia seed, 8 16 parts of Semen Coicis, 26 parts of Radix Angelicae Sinensis.Preparation method includes step picking of raw material, mixing compounding, filling, bubble-cap pressing plate and packaging, and the invention discloses a kind of aloetic anti-acne drug and preparation method thereof, which being capable of effectively anti-acne, ecchymose removing, antibacterial anti-inflammatory.Especially there is remarkable efficacy to complexion is withered and yellow caused by acne, acne, papule epifolliculitis, seborrheic dermatitis, pachylosis, color spot, freckle, abdominal distension, apocleisis, insomnia, endocrine disorder.Vivotoxin can be effectively excluded simultaneously, repair scar, strengthen immunity.
Description
Technical field
The present invention relates to medical anti-acne fields more particularly to a kind of aloetic anti-acne drug and preparation method thereof.
Background technology
With the fast development of society, people’s lives tempo increase, operating pressure is larger, and long-term evening such as sleeps at the bad habits
Endocrine disturbance can be caused, skin is caused various problems occur, such as acne, acne, papule epifolliculitis, seborrheic dermatitis, skin
Complexion caused by coarse, color spot, freckle, endocrine disorder is withered and yellow etc., these problems not only influence the health of people, also tight
Ghost image rings personal image.Existing product for resolving poxes includes cosmetics and drug, most of cosmetics price with anti-acne effect
Costliness, anti-acne effect unobvious, and existing anti-acne pharmaceutical chemistry ingredient toxicity is larger, side effect is more apparent, and drug withdrawal can recur
Rate is higher, and safety does not ensure.
Invention content
It is an object of the invention to overcome the deficiencies in the prior art, and provide a kind of aloetic anti-acne drug and its preparation
Method, which uses aloe powder, and for key component, Small side effects, anti-acne effect is good, can improve endocrine disturbance, can be effective
It excludes vivotoxin, repair scar, strengthen immunity.
The solution have the advantages that be achieved:A kind of aloetic anti-acne drug, by each of following parts by weight
Component forms:8-19 parts of aloe full leaf freeze-dried powder, 18-37 parts of aloe full leaf ovendry power, 2-8 parts of Radix Glycyrrhizae, 8-17 parts of cassia seed, the heart of a lotus seed
Rice 8-16 parts, 2-6 parts of Radix Angelicae Sinensis.
Preferably, which is grouped as by each group of following parts by weight:10-15 parts of aloe full leaf freeze-dried powder, aloe is complete
20-35 parts of leaf ovendry power, 3-5 parts of Radix Glycyrrhizae, 10-15 parts of cassia seed, 10-15 parts of Semen Coicis, 3-5 parts of Radix Angelicae Sinensis.
Preferably, which is grouped as by each group of following parts by weight:12 parts of aloe full leaf freeze-dried powder, aloe full leaf dry
28 parts of dry powder, 4 parts of Radix Glycyrrhizae, 13 parts of cassia seed, 12 parts of Semen Coicis, 5 parts of Radix Angelicae Sinensis.
Preferably, a kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following parts by weight:8-19 parts of aloe full leaf freeze-dried powder,
18-37 parts of aloe full leaf ovendry power, 2-8 parts of Radix Glycyrrhizae, 8-17 parts of cassia seed, 8-16 parts of Semen Coicis, 2-6 parts of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule mounted box that will be made, vanning, outbound after inspection.
Pharmacological property is analyzed:
Aloe full leaf freeze-dried powder selects Aloe Barbadensis Miller fresh leaf to extract through advanced technologies, stabilization processes, nothing after room temperature film degerming
Bacterium is filling, then is made through vacuum freeze drying, contains barbaloin, aloe polysaccharide, anthraquinone compounds, rutin, protein, organic
The plurality of active ingredients such as acid, amino acid and trace element are pale yellow powder, and gas stink is bitter, improve a poor appetite, large intestine delay let out,
Soothing the liver invigorating the spleen and the effect of heat-clearing and fire-reducing, can strengthen stomach function, improve the immunity of the human body and build up health, and there is certain ease constipation to lead to
Just function.Easily absorb, it is without any side effects to human body, there are antibacterial and anti-inflammation functions.
Aloe full leaf ovendry power is selected 2 years or more ripe Aloe Barbadensis Miller fresh leafs of growth, is carried out after drying ultra-fine
Crushing and processing are made, and relax bowel, liver-protecting and alcoholism-relieving, beautifying face and moistering lotion and other effects.
Radix Glycyrrhizae, alias:Licorice, unpeeled RADIX GLYCYRRHIZAE, ural licorice root tip, sweet tea root, lantern, honeywort, state is old, Herba Hedyotis cantonensis, powder are careless, honey is sweet,
It is mild-natured, sweet in flavor, return 12 warps.There are removing toxic substances, eliminating the phlegm, analgesic, spasmolysis so that the pharmacological actions such as anticancer.In the traditional Chinese medical science, Radix Glycyrrhizae tonifying spleen
QI invigorating grows cough moistening lung, emergency removing toxic substances, hundred medicines of reconciliation.Clinical practice point " raw to use " is not with " honey is processed ".It is raw to be swollen with curing mainly throat
Bitterly, pain subcutaneous ulcer sore, gastrointestinal ulceration and antidote poison, food poisoning etc.;Honey toast cures mainly spleen and stomach function decline, and big loose stool is thin, weary
Power fever and cough, palpitaition etc..There is following and effect:1. antiacid, Radix Glycyrrhizae has similar cortex hormone of aadrenaline sample to make
With having inhibiting effect to gastroxia caused by histamine;And there is antiacid and alleviation gastrointestinal smooth muscle spasm effect;2. town
Cough, licoflavone, extract of licorice root and enoxolone have apparent antitussive effect;Phlegm-dispelling functions are also more significant, action intensity
For glycyrrhizic acid>Licoflavone>Extract of licorice root;3. anti-inflammatory, antiallergy, Radix Glycyrrhizae is also anti-inflammatory, anti-allergic effects, can protect inflammation
Throat and tunica mucosa tracheae, extract of licorice root and glycyrrhizic acid have certain poisonous substances the detoxication of similar glucuronic acid;4. balance female
Property body in hormone, the symptom that Radix Glycyrrhizae is commonly used to treat with climacteric and comes is a kind of similar because containing glycyrrhizin in Radix Glycyrrhizae
The compound of hormone, it helps to balance the hormone-content in women body;5. anti-curing oncoma, the hypo acid contained by Radix Glycyrrhizae can block cause
The effect of cancer object induced tumor growth.
Cassia seed, alias:Cassia occidentalis, sheep are bright, goat's horn, horseshoe Cassia, go back pupil, bullshit beans, false mung bean, horseshoe, thousand
In light, celery certainly, swordweed.The salty hardship of taste, it is cool in nature;Return liver, courage, kidney channel.Expelling wind and clearing away heat, detoxification and promoting urination.Main anemopyretic cold, influenza,
Acute conjunctivitis, jaundice with damp-heat pathogen, acute and chronic nephritis, under, scrofula, sore carbuncle furuncle, mastitis.There is following and effect;
1. improving eyesight for diseases such as red eye, swell pain, the more tears of photophobia, optic atrophies, alleviates the diseases such as red eye, swell pain, the more tears of photophobia, is in irascibility
It disturbs or the diseases such as wind-heat;2. preventing optic atrophy, optic atrophy, mostly as caused by kidney deficiency and liver, cassia seed clears liver and improving eyesight, often
It is equal with tonic liver renal drug such as SEMEN ASTRAGALI COMPLANATI, the fruit of glossy privet, the fruit of Chinese wolfberry, Radix Rehmanniae and uses, controls optic atrophy;3. relieving asthma, cholagogic, guarantor
Liver, decompression, contained rheum emodin, Rhein have to human body relieving asthma, cholagogic, liver protection, antihypertensive effect, and have certain antibacterial, anti-inflammatory make
With;4. blood pressure lowering, modern clinic treats hyperlipidemia with cassia seed, cassia seed decocting or tablets is made;5. cardiac stimulant, contained
Emodin monoglucoside, emodin anthrone, Physcion, having reduces serum cholesterol and cardiac effect;6. it relaxes bowel.
The nutritive value of cassia seed:Cassia seed is in addition to containing carbohydrate, protein, fat, also containing steroidal compounds, Chrysophanol, rheum emodin
Deng trace elements iron, zinc, manganese, copper, nickel, cobalt, molybdenum etc. also necessary to human body.Cassia seed element has a- hydroxyls, can be with metal element
Complex compound is synthesized, is had a significant impact to metallic element absorption.In addition, civil common cassia seed stir-bake to yellowish end, on behalf of the tea, have prevention and
Treat the healthcare function of disease.
Semen Coicis, alias:SEMEN COICIS, Job's tears, coix seed, maize rice, the seed of jog's tears, myotonin, ditch rice, the seed of jog's tears, adlay.Nature and flavor
It is sweet it is light be slightly cold, have inducing diuresis for removing edema, invigorating spleen to remove dampness, relaxing muscles and tendons eliminating impediment, clearing away heat and eliminating pus and other effects, be common damp-clearing drug.Have
Following effect and effect:1. cancer-resisting, contained by selenium element can effectively inhibit the breeding of cancer cell, available for clouds cancer, son
The auxiliary treatment of cervical carcinoma, Healthy People often eat Semen Coicis, and body can be made spry and light, reduce tumor invasion probability.Especially with the insufficiency of the spleen with overabundance of dampness
It is more suitable that tumor in digestive tract and phlegm heat hold wet lung cancer under the arm, and in Japan, Semen Coicis is seen as typical " anticancer food ", moreover it is possible to be mitigated
The toxic side effect of tumor patient chemicotherapy;2. strengthening the spleen and stomach promotees metabolism, Semen Coicis is because containing multivitamin and minerals, there is promotion
Metabolism and the effect for reducing stomach and intestine burden, can be used as in disease or the help food of weak patients after being ill, often edible Semen Coicis
Food is also effective to diseases such as chronic enteritis, indigestions;3. it is a kind of containing certain vitamin E in Semen Coicis skin whitening
Beauty food, often feeding can keep human skin gloss fine and smooth, eliminate acne, color spot, improve the colour of skin;And it is for by virus
Wart caused by infection etc. has certain therapeutic effect;4. clearing damp and promoting diuresis has inducing diuresis for removing edema, invigorating spleen to remove dampness, relaxing muscles and tendons eliminating impediment, heat-clearing
Apocenosis and other effects is common damp-clearing drug.
Radix Angelicae Sinensis, alias:Angelica powder, it is dry return, horse hair Radix Angelicae Sinensis, the Qin which, horse hair is returned, cloud is returned, western Radix Angelicae Sinensis, Min Radix Angelicae Sinensis.It is warm-natured, taste
Gan Xin.The thoughts of returning home, liver, the spleen channel.Benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturize laxation.Irregular menstruation, Amenorrhea abdominal pain are controlled, abdominal mass knot gathers, collapses
Leakage;Headache due to deficiency of blood, dizziness, Impotence numbness;Intestines are dry and shit is difficult, weight after dysentery characterized by blood in the stool;Ulcer sore is stolen, injury from falling down.There is following and effect:
1. enriching blood, body hematopoiesis function, raising red blood cell, leucocyte and content of hemoglobin can be remarkably promoted;2. Adjust-blood lipid inhibits blood
Platelet agglomerates, antithrombotic, adjusts blood fat;3. blood pressure lowering resists myocardial ischemia, arrhythmia cordis, blood vessel is expanded, is reduced blood pressure;4. increase
Strong immunity enhances immune, anti-inflammatory, liver protection, radioresistance, anti-oxidant and removing free radical etc..The nutritive value of Radix Angelicae Sinensis:Radix Angelicae Sinensis master
Contain sucrose, a variety of amino acid, volatile oil and n-butene, lactone, niacin, ferulic acid and half terpenoid, also containing dimension
Raw element A, vitamin E, volatile oil, arginine and several mineral materials.
The beneficial effects of the invention are as follows:The invention discloses a kind of aloetic anti-acne drug and preparation method thereof, the medicines
Object being capable of effectively anti-acne, ecchymose removing, antibacterial anti-inflammatory.Especially to acne, acne, papule epifolliculitis, seborrheic dermatitis, pachylosis,
Complexion caused by color spot, freckle, abdominal distension, apocleisis, insomnia, endocrine disorder is withered and yellow remarkable efficacy.It can effectively exclude body simultaneously
Endotoxin repairs scar, strengthen immunity.
Specific embodiment
Embodiment 1:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder
8Kg, 18 Kg of aloe full leaf ovendry power, 2 Kg of Radix Glycyrrhizae, 8 Kg of cassia seed, 8 Kg of Semen Coicis, 2 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:Aloe full leaf freeze-dried powder 8Kg, aloe full leaf
18 Kg of ovendry power, 2 Kg of Radix Glycyrrhizae, 8 Kg of cassia seed, 8 Kg of Semen Coicis, 2 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Embodiment 2:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder 19
Kg, 37 Kg of aloe full leaf ovendry power, 8 Kg of Radix Glycyrrhizae, 17 Kg of cassia seed, 16 Kg of Semen Coicis, 6 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:19 Kg of aloe full leaf freeze-dried powder, aloe are complete
37 Kg of leaf ovendry power, 8 Kg of Radix Glycyrrhizae, 17 Kg of cassia seed, 16 Kg of Semen Coicis, 6 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Embodiment 3:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder
8Kg, 37 Kg of aloe full leaf ovendry power, 2 Kg of Radix Glycyrrhizae, 17 Kg of cassia seed, 8 Kg of Semen Coicis, 6 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:Aloe full leaf freeze-dried powder 8Kg, aloe full leaf
37 Kg of ovendry power, 2 Kg of Radix Glycyrrhizae, 17 Kg of cassia seed, 8 Kg of Semen Coicis, 6 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Embodiment 4:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder
10Kg, 20 Kg of aloe full leaf ovendry power, 3 Kg of Radix Glycyrrhizae, 10 Kg of cassia seed, 10 Kg of Semen Coicis, 3 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:Aloe full leaf freeze-dried powder 10Kg, aloe are complete
20 Kg of leaf ovendry power, 3 Kg of Radix Glycyrrhizae, 10 Kg of cassia seed, 10 Kg of Semen Coicis, 3 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Embodiment 5:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder
15Kg, 35 Kg of aloe full leaf ovendry power, 5 Kg of Radix Glycyrrhizae, 15 Kg of cassia seed, 15 Kg of Semen Coicis, 5 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:Aloe full leaf freeze-dried powder 15Kg, aloe are complete
35 Kg of leaf ovendry power, 5 Kg of Radix Glycyrrhizae, 15 Kg of cassia seed, 15 Kg of Semen Coicis, 5 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Embodiment 6:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder
10Kg, 35 Kg of aloe full leaf ovendry power, 3 Kg of Radix Glycyrrhizae, 15 Kg of cassia seed, 10 Kg of Semen Coicis, 5 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:Aloe full leaf freeze-dried powder 10Kg, aloe are complete
35 Kg of leaf ovendry power, 3 Kg of Radix Glycyrrhizae, 15 Kg of cassia seed, 10 Kg of Semen Coicis, 5 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Embodiment 7:A kind of aloetic anti-acne drug, is grouped as by each group of following weight:Aloe full leaf freeze-dried powder
12Kg, 28 Kg of aloe full leaf ovendry power, 4 Kg of Radix Glycyrrhizae, 13 Kg of cassia seed, 12 Kg of Semen Coicis, 5 Kg of Radix Angelicae Sinensis.
A kind of preparation method of aloetic anti-acne drug, includes the following steps:
A, picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and
Radix Angelicae Sinensis medicinal material, and powdering is ground to medicinal material, it is weighed by following weight:Aloe full leaf freeze-dried powder 12Kg, aloe are complete
28 Kg of leaf ovendry power, 4 Kg of Radix Glycyrrhizae, 13 Kg of cassia seed, 12 Kg of Semen Coicis, 5 Kg of Radix Angelicae Sinensis;
B, mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
C, it fills:The material after being granulated in step B is filled in capsule using capsule filler;
D, bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
E, it packs:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Most preferred formula is the formula in embodiment 7.
Investigation and analysis:
This investigation:
1st, this investigation 112 patient of case, patient symptom includes acne, acne, papule epifolliculitis and seborrheic dermatitis etc., main
Symptom is wanted as acne and acne, wherein 72 people of male patient, 40 people of female patient, the age, average age was between 14-30 Sui
22 years old, patient is randomly divided into 7 groups by statistics, every group is 16 people.
2nd, therapeutic scheme
First group is treated using the drug of embodiment 1;
Second group is treated using the drug of embodiment 2;
Third group is treated using the drug of embodiment 3;
4th group is treated using the drug of embodiment 4;
5th group is treated using the drug of embodiment 5;
6th group is treated using the drug of embodiment 6;
7th group is treated using the drug of embodiment 7.
3rd, efficacy assessment standard:
It cures:Complete recession 100%, no clinical symptoms at acne.
It improves:Subside about 80% at acne, there is slight pain to itch symptom.
It takes effect:Recession about 30% at acne, aching symptom of itching has minor responses.
In vain:Quantity without recession sign or even acne at acne increases, and pain is itched unbearably.
Recurrence:It cures in 6 months without clinical symptoms.
4th, the effect after treating 15 days:
According to the investigation statistics of above table, a kind of aloetic anti-acne drug provided by the invention is quick, treatment effect
Fruit is good, and recurrence rate is low, wherein in the drug of 7 embodiments provided by the invention, the drug of embodiment 7 is optimum formula, is cured
Rate highest, recurrence rate 0.
Clinical case:
Case 1:Zhang, man, 30 years old, face had acne and acne to have 3 years, and recurrence is occurred as soon as after western medicine, after drug withdrawal
Symptom began to use the drug of the embodiment of the present invention 7 to be treated, 2 times a day, 2 tablets each time, continuously on January 28th, 2016
After taking 15 days, the acne and acne of patient facial region subside completely, without rebound phenomenon after drug withdrawal, so far still without any relapse indications.
Case 2:Zhao, female, 18 years old, in June, 2015, face started long whelk, was implemented using the present invention in March, 2016
The drug of example 7 is treated, and 2 times a day, two every time, is continuously taken 13 days, and the whelk of patient facial region subsides completely, is continued
It takes half a month, acne print is significantly desalinated, without any relapse indications after drug withdrawal.
Claims (4)
1. a kind of aloetic anti-acne drug, it is characterised in that:It is grouped as by each group of following parts by weight:Aloe full leaf is lyophilized
8-19 parts of powder, 18-37 parts of aloe full leaf ovendry power, 2-8 parts of Radix Glycyrrhizae, 8-17 parts of cassia seed, 8-16 parts of Semen Coicis, 2-6 parts of Radix Angelicae Sinensis.
2. a kind of aloetic anti-acne drug according to claim 1, it is characterised in that:By each group of following parts by weight
It is grouped as:10-15 parts of aloe full leaf freeze-dried powder, 20-35 parts of aloe full leaf ovendry power, 3-5 parts of Radix Glycyrrhizae, 10-15 parts of cassia seed, the heart of a lotus seed
Rice 10-15 parts, 3-5 parts of Radix Angelicae Sinensis.
3. a kind of aloetic anti-acne drug according to claim 1, it is characterised in that:By each group of following parts by weight
It is grouped as:12 parts of aloe full leaf freeze-dried powder, 28 parts of aloe full leaf ovendry power, 4 parts of Radix Glycyrrhizae, 13 parts of cassia seed, 12 parts of Semen Coicis, Radix Angelicae Sinensis
5 parts.
4. a kind of a kind of preparation method of aloetic anti-acne drug according to claim 1, it is characterised in that;Including with
Lower step:
Picking of raw material:The aloe full leaf freeze-dried powder of selection check qualification, aloe full leaf ovendry power, Radix Glycyrrhizae, cassia seed, Semen Coicis and work as
Return medicinal material, and powdering is ground to medicinal material, parts by weight as described in claim 1 are weighed;
Mixing compounding:Each component in step A is sufficiently mixed, and mixed component is granulated;
Filling:The material after being granulated in step B is filled in capsule using capsule filler;
Bubble-cap pressing plate:The capsule in step C is closed using bubble-cap trigger squeeze;
Packaging:The capsule pressing plate mounted box that will be made in step D, vanning, outbound after inspection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810193532.XA CN108186937A (en) | 2018-03-09 | 2018-03-09 | A kind of aloetic anti-acne drug and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810193532.XA CN108186937A (en) | 2018-03-09 | 2018-03-09 | A kind of aloetic anti-acne drug and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108186937A true CN108186937A (en) | 2018-06-22 |
Family
ID=62595454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810193532.XA Pending CN108186937A (en) | 2018-03-09 | 2018-03-09 | A kind of aloetic anti-acne drug and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108186937A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109646383A (en) * | 2019-01-21 | 2019-04-19 | 秋臣化妆品有限公司 | A kind of autumn minister aloe gel and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000044997A (en) * | 1998-07-27 | 2000-02-15 | Kenki Boku | Skin care soap |
CN106333913A (en) * | 2016-07-01 | 2017-01-18 | 高国龙 | Traditional Chinese medicinal composition for removing spots and acnes, and preparation method thereof |
CN106668629A (en) * | 2015-11-11 | 2017-05-17 | 王国成 | Traditional Chinese recipe for treating whelk |
CN106692766A (en) * | 2015-11-12 | 2017-05-24 | 张瑞芹 | Traditional Chinese medicine formula for treatment of acnes |
-
2018
- 2018-03-09 CN CN201810193532.XA patent/CN108186937A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000044997A (en) * | 1998-07-27 | 2000-02-15 | Kenki Boku | Skin care soap |
CN106668629A (en) * | 2015-11-11 | 2017-05-17 | 王国成 | Traditional Chinese recipe for treating whelk |
CN106692766A (en) * | 2015-11-12 | 2017-05-24 | 张瑞芹 | Traditional Chinese medicine formula for treatment of acnes |
CN106333913A (en) * | 2016-07-01 | 2017-01-18 | 高国龙 | Traditional Chinese medicinal composition for removing spots and acnes, and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
胡晓艳等: "中国芦荟治疗寻常痤疮临床研究", 《实用中医药杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109646383A (en) * | 2019-01-21 | 2019-04-19 | 秋臣化妆品有限公司 | A kind of autumn minister aloe gel and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104509619B (en) | A kind of traditional Chinese medicine slimming health tea and preparation method thereof | |
CN105266149A (en) | Herba dendrodii officinalis compound health-care capsule and preparation method thereof | |
CN104740583B (en) | It is a kind of to be used to alleviate Chinese medicine preparation of Crohn disease and preparation method thereof | |
CN103859373A (en) | Formula and preparation method of life cultivation and health preservation food helpful for preserving health during menstrual period | |
CN108066384A (en) | A kind of Chinese medicine preparation with strengthen immunity and preparation method thereof | |
CN102552537B (en) | Chinese medicinal composition for treating qi and blood loss | |
CN108186937A (en) | A kind of aloetic anti-acne drug and preparation method thereof | |
CN103932176B (en) | A health food composition with the function of assisting in lowering blood fat, its preparation method and application | |
TWI721367B (en) | Composition for regulating endocrine, improving immunity, delaying aging and preventing or treating constipation, its application and preparation method thereof | |
CN114177261A (en) | Chinese herbal medicine formula for preventing and treating chronic diseases and resisting cancer and protecting health | |
CN105031170A (en) | Healthcare foot bath powder and preparing method thereof | |
CN105727156A (en) | Cancer inhibiting and pain relieving cataplasm and preparation method thereof | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN108434373A (en) | A kind of Chinese medicine composition for treating acne, eczema and butterfly macules | |
CN100352473C (en) | Tea and Chinese wolfberry fruit extracts composition and use thereof | |
Dharmananda | Coix: Food and Medicine | |
CN103356984B (en) | Traditional Chinese medicine composition for preventing and treating female iron deficiency anemia | |
CN118873617A (en) | A Chinese medicine composition for treating esophageal cancer and its preparation method and application | |
CN112156159A (en) | Conditioning tablet and preparation method thereof | |
CN103893486A (en) | Traditional Chinese medicine composition for treating liver cancer | |
CN113288924A (en) | Traditional Chinese medicine composition and preparation for enhancing immunity | |
CN104013850A (en) | Pharmaceutical composition for relieving malaise after chemoradiotherapy and preparation method thereof | |
HK1263179A1 (en) | Preparation method and application of a composition with reinforcing kidney and nourishing yin | |
CN109865003A (en) | The ointment and preparation method thereof for treating cutaneous pruritus caused by acne and eczema | |
CN110522881A (en) | A kind of prevention and treatment lipoma Chinese medicine composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180622 |